Capnocytophaga canimorsus endophthalmitis following cataract surgery

Clinical and Experimental Ophthalmology

Volumn 30, Issue 5, 2002, Pages 375-377

  Phipps, Simon E ^a   Tamblyn, David M ^a   Badenoch, Paul R ^b,c  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Capnocytophaga canimorsus; Cataract; Clindamycin; Endophthalmitis; Vitreous humour

Indexed keywords

ANTIBIOTIC AGENT; ATROPINE; CEFTAZIDIME; CLINDAMYCIN; DEXAMETHASONE; OFLOXACIN; PREDNISOLONE; TOBRAMYCIN; VANCOMYCIN;

AGED; ARTICLE; BACILLUS; BACTERIAL INFECTION; BACTERIUM CULTURE; CAPNOCYTOPHAGA; CASE REPORT; CAT; CATARACT EXTRACTION; DOG; ENDOPHTHALMITIS; EYE; GRAM STAINING; HUMAN; LENS IMPLANTATION; MALE; MOUTH FLORA; NONHUMAN; VISUAL ACUITY; VITREOUS BODY;

AGED; AGED, 80 AND OVER; CAPNOCYTOPHAGA; CEFTAZIDIME; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; PHACOEMULSIFICATION; VANCOMYCIN; VISUAL ACUITY; VITREOUS BODY;

EID: 0036798320     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-9071.2002.00561.x     Document Type: Article

References (13)

1. Mutters R. Actinobacillus, Capnocytophaga, Eikenella, Kingella, and other fastidious or rarely encountered Gram-negative rods. In: Murray PR, Baron EJ, Pfaller MA, Tenoveer FC, Yolken RH (eds). Manual of Clinical Microbiology, 7th edn. Washington: American Society for Microbiology, 1999; 561-71.
2. Vandamme P, Vancanneyt M, van Belkum A et al. Polyphasic analysis of strains of the genus Capnocytophaga and Centers for Disease Control group DF-3. Int. J. Syst. Bacteriol. 1996; 46: 782-91.
3. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in humans: review of the literature and case reports. Eur. J. Epidemiol. 1996; 12: 521-33.
4. Alexandrakis G, Palma LA, Miller D, Alfonso EC. Capnocytophaga keratitis. Ophthalmology 2000; 107: 1503-6.
5. de Smet MD, Chan CC, Nussenblatt RB, Palestine AG. Capnocytophaga canimorsus as the cause of a chronic corneal infection. Am. J. Ophthalmol. 1990; 109: 240-42.
6. Rubsamen PE, McLeish Wm, Pfugfelder S, Miller D. Capnocytophaga endophthalmitis. Ophthalmology 1993; 100: 456-9.
7. Zimmer-Galler IE, Pach JM. Capnocytophaga canimorsus endophthalmitis. Retina 1996; 16: 163-4.
8. Gill VJ. Capnocytophaga. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases, 5th edn. Philadelphia; Churchill Livingstone, 2000; 2441-4.
9. Rummens JL, Gordts B, Van Landuyt HW. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents. Antimicrob. Agents Chemother. 1986; 30: 739-42.
10. Hawkey PN, Smith SD, Haynes J, Malnick H, Forlenza SW. In vitro susceptibility of Capnocytophaga species to antimicrobial agents. Antimicrob. Agents Chemother. 1987; 31: 331-2.
11. Cekic O, Batman C, Yasar U, Basci NE, Bozkurt A, Kayaalp SO. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina 1998; 18: 521-5.
12. Forlenza SW, Newman MG, Horikoshi AL, Blachman U. Antimicrobial susceptibility of Capnocytophaga. Antimicrob. Agents Chemother. 1981; 19: 144-6.
13. Soderling E, Makinen PL, Syed S, Makinen KK. Biochemical comparison of proteolytic enzymes present in rough- and smooth-surfaced capnocytophagas isolated from the subgingival plaque of periodontitis patients. J. Periodontal Res. 1991; 26: 17-23.